Hims & Hers Health (HIMS) just got wrecked after missing Q2 revenue and triggering major concerns around its GLP-1 weight-loss pipeline. Is this a rare buying opportunity—or a regulatory disaster in disguise?
Join Dave on "Am I Catching a Falling Knife?" as we deep dive into:
👉 Market narrative vs fundamentals
👉 DCF and PEG valuation models
👉 Buy zones for risk-tolerant traders
This episode blends sharp satire with serious data so you can navigate volatility with confidence. Not financial advice—just financial comedy.
#HIMS #stocks #fallingknife #GLP1 #telehealth #stockmarket #financememes
